Abstract
Leptin produces effects in central nervous system and peripheral tissues via its specific receptors. Leptin also stimulates nitric oxide release in a concentration-dependent manner. In this study, our aim was to test the hypothesis that whether leptin has a modulatory role on endothelium or smooth muscle function in streptozotocin (STZ)-induced diabetic rats. Wistar-Albino rats were divided into four groups: 1 – Control, 2 – Diabetic, 3 – Control + leptin and 4 – Diabetic + leptin. Experimental diabetes was produced by intraperitoneal injection of a single dose of STZ (55 mg/kg). Diabetes was determined by increased fasting blood glucose level on the 7th day of the experiment. Leptin (0.1 mg/kg/day) was administered intraperitoneally for 5 days. At the end of the 5th day, thoracic aortas were isolated and phenylephrine (Phe)-induced contractions and acetylcholine (ACh)-induced relaxations of each group were estimated. In diabetic rats, Phe-induced contractility was increased (p < 0.05). Leptin pre-treatment increased the Phe-induced contractility significantly in aortic rings obtained from diabetic rats (p < 0.05). In normal rats, leptin administration produced only a slight and non-significant increase in Phe-induced contractions. Although the relaxant responses were decreased in diabetic rats, leptin administration enhanced the ACh-induced relaxation in both normal and diabetic animals significantly. As a conclusion; chronic leptin pre-treatment caused a significant increase both in Phe-induced contractions and ACh-induced Endothelial-Derived Relaxing Factor (EDRF)/Nitric oxide-mediated relaxations in the aortic rings isolated from streptozotocin-induced diabetic rats. This peptide hormone caused a significant increase in the relaxations obtained by ACh while not inducing a significant alteration in the contractile effect of Phe in control rats.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer L: Leptin enhaces the calcification of vascular cells: artery wall as a target of leptin. Circ Res 88(9): 954–960, 2001
Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540–543, 1995
Schwartz MW, Seeley RJ, Ampfield LA, Burn P, Baskin DG: Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98: 1101–1106, 1996
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425–432, 1994
Levin N, Nelson C, Gurney A, Vandlen R, de Sauvage F: decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci USA 93: 1726–1730, 1996
Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB: Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339–343, 2002
Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM: Role of stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297: 240–243, 2002
Seufert J: Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 53(1): 152–158, 2004
Shek EW, Brands MW, Hall JE: Hypertension Jan;31(1 Pt 2): 409–414, 1998
Dunbar JC, Hu Y, Lu H: Intracerebroventricular leptin, increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 46: 2040–2043, 1997
Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL: Receptor-mediated regional sympathetic nerve actions by leptin. J Clin Invest 100: 1–9, 1997
Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM: Periadventitial fat releases a vascular relaxing factor. Faseb J 16(9): 1057–1063, 2002
Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Floreres Riveros JR: Biological action of leptin as an angiogenic factor. Nature 281: 1683–1686, 1998
Lembo G, Vecchione C, Fratta L, Marino G, Trimarco V, Amati G, Trimarco B: Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 49: 293–297, 2000
Vecchione C, Aretini A, Maffei A, Marino G, Selvetella G, Poulet R, Trimarco V, Frati G, Lembo G: Cooperation between insulin and leptin in the modulatin of vascular tone. Hypertension 42: 166–170, 2003
Frunhberk G: Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 48(4): 903–908, 1999
Szkudelski T: The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50: 536–546, 2001
Francis J, Mohankumar SMJ, Quadri SK: Systemic administration of lipopolysaccharide increases plasma leptin levels. Endocrine 10: 291–295, 1999
Wauters M, Considine VR, van Gaal LF: Human leptin: from an adipocyte hormone to an endocrine mediator. Euro J Endocr 143: 293–311, 2000
Hintz K, Aberle NS, Ren J: Insulin resistance induces hyperleptinemia, cardiac contractile dysfunction but not cardiac leptin resistance in ventricular myocytes. Int J Obes Relat Metab Disord Oct 27(10): 1196–1203, 2003
Kennel WB, Brand N, Skinner JJ, Dauber TR, McNamara PM: The relation of adiposity to blood pressure and development of hypertension: the Framingram study. Ann Intern Med 67: 48–59, 1967
Manson JE, Willet WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE: Body weight and mortality among women. N Engl J Med 333: 677–685, 1995
Weber LP, Macleod KM: Influence of streptozotocin diabetes on the alpha-1 adrenoceptor and asssociated G proteins in rat arteries. J Pharmacol Exp Ther 283: 1469–1478, 1997
Fortuno A, Rodriguez A, Gomez-Ambrosi J, Muniz P, Salvador J, Diez J, Fruhbeck G: Leptin inhibitis angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta. Endocrinology Sept 143(9): 3555–3560, 2002
Carlyle M, Oscar B, Jones JK, John EH: Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 39(2): 496–501, 2002
Orbay T, Ercan ZS, Seçkin Z, Göksel M: Pharmacological response of endothelium to microvascular temporary clip application. Surg Neurol 33: 192–194, 1990
Ercan ZS, Türker RK: Propranolol enhances acetylcholine-induced relaxation in the various arterial segments of rabbit. Arch Int Pharmacodyn Ther 294: 185–193, 1998
Altan M, Karasu C, Özüarı A: The effects of type-1 and type-2 diabetes on endothelium-dependent relaxation in rat aorta. Pharm Bioc Behav 33: 519–522, 1989
Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, Gentile MT, Fratta L, Trimarco V, Lembo G: Leptin effect on endothelial nitric oxide is mediated through Akt-Endothelial nitric oxide synthase phosphorylation pathway. Diabetes 51(1): 168–173, 2002
Matsuda K, Teragawa H, Fukuda Y, Nakagawa K, Higashi Y, Chayama K: Leptin causes nitric-oxide independent coronary artery vasodilatation in humans. Hypertens Res 26(2): 147–152, 2003
Kimura K, Tsuda K, Baba A, Kowabe T, Boh-oka S, Ibata M, Moriwaki C, Hano T, Nishio I: Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun 273: 745–749, 2000
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Özer, Ç., Gülen, Ş., Dileköz, E. et al. The effect of systemic leptin administration on aorta smooth muscle responses in diabetic rats. Mol Cell Biochem 282, 187–191 (2006). https://doi.org/10.1007/s11010-006-1927-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11010-006-1927-0